Because previously studies have reported that dysregulation of USP15 could result in paclitaxel resistance in HeLa cells [9], we wanted to investigate whether USP15 downregulation is associated with CML Imatinib resistance. This evidence concerns the gene USP15 and chronic myelogenous leukemia, BCR-ABL1 positive.